Treatment guidelines of chronic inflammatory demyelinating polyneuropathy in China
Author(s) -
Liying Cui,
Chuanqiang Pu,
Xue-Qiang Hu
Publication year - 2017
Publication title -
neuroimmunology and neuroinflammation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 4
eISSN - 2349-6142
pISSN - 2347-8659
DOI - 10.20517/2347-8659.2016.14
Subject(s) - medicine , china , publishing , chronic inflammatory demyelinating polyneuropathy , medical education , library science , immunology , law , computer science , political science , antibody
Chronic inflammatory demyelinating polyradiculoneuropathy, or chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired immune-mediated inflammatory disorder at the peripheral nervous system, in which the progression is chronic and also remission relapse. In most cases, it is also associated with cerebrospinal fluid (CSF) protein-cell separation. Electrophysiologically, the peripheral nerve conduction velocity decreases, blocks and characterized as discrete abnormal waveform. Pathologically, there is also multifocal demyelination of myelinated fibers, nerve endometrial edema, inflammatory cell infiltration, etc.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom